Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Allergy2020Vol. 75(8), pp. 1927–1938
Citations Over TimeTop 10% of 2020 papers
Jakub Trizuljak, Wolfgang R. Sperr, Lucie Nekvindová, Hanneke Oude Elberink, Karoline V. Gleixner, Aleksandra Górska, Magdalena Lange, Karin Hartmann, Anja Illerhaus, Massimiliano Bonifacio, Cecelia Perkins, Chiara Elena, Luca Malcovati, Anna Belloni Fortina, Khalid Shoumariyeh, Mohamad Jawhar, Roberta Zanotti, Patrizia Bonadonna, Francesca Caroppo, Alexander Zink, Massimo Triggiani, Roberta Parente, Nikolas von Bubnoff, Akif Selim Yavuz, Hans Hägglund, Mattias Mattsson, Jens Panse, Nadja Jäkel, Alex Kilbertus, Olivier Hermine, Michel Arock, David Fuchs, Vito Sabato, Knut Brockow, Agnes Bretterklieber, Marek Niedoszytko, Björn van Anrooij, Andreas Reiter, Jason Gotlib, Hanneke C. Kluin‐Nelemans, Jiřı́ Mayer, Michael Doubek, Peter Valent
Abstract
Our data confirm the clinical impact of the WHO classification that separates ISM from CM and from other SM variants.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)